Eton Pharmaceuticals Files 8-K

Ticker: ETON · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1710340

Sentiment: neutral

Topics: corporate-filing, 8-k

TL;DR

Eton Pharma filed an 8-K on 3/3/25 with updated corporate info.

AI Summary

Eton Pharmaceuticals, Inc. filed an 8-K on March 3, 2025, reporting other events and financial statements. The filing details the company's principal executive offices located at 21925 W. Field Parkway, Suite 235, Deer Park, Illinois, 60010-7208, and its telephone number is (847) 787-7361. The company is incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

This filing provides updated corporate information and signals ongoing regulatory compliance for Eton Pharmaceuticals.

Risk Assessment

Risk Level: low — This is a routine corporate filing with no immediate financial or operational impact indicated.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Eton Pharmaceuticals?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 3, 2025.

Where are Eton Pharmaceuticals' principal executive offices located?

Eton Pharmaceuticals' principal executive offices are located at 21925 W. Field Parkway, Suite 235, Deer Park, Illinois, 60010-7208.

What is Eton Pharmaceuticals' telephone number?

Eton Pharmaceuticals' telephone number is (847) 787-7361.

In which state is Eton Pharmaceuticals incorporated?

Eton Pharmaceuticals is incorporated in Delaware.

When does Eton Pharmaceuticals' fiscal year end?

Eton Pharmaceuticals' fiscal year ends on December 31.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding Eton Pharmaceuticals, Inc. (ETON).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing